SNGX - ソリジェニックス (Soligenix Inc.)

SNGXのニュース

   Soligenix beats by $0.05, misses on revenue  2019-05-14
Soligenix (NASDAQ: SNGX ): Q1 GAAP EPS of -$0.09 beats by $0.05 . More news on: Soligenix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …
   Soligenix Announces Recent Accomplishments And First Quarter 2019 Financial Results  2019-05-14 PR Newswire
PRINCETON, N.J. , May 14, 2019 /PRNewswire/ --Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need,announced today its re…
   Soligenix -- Advancing to Important Inflection Points With Two Pivotal Phase 3 Clinical Trials  2019-04-23 PR Newswire
PRINCETON, N.J. , April 23, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX)(Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an…

calendar